The abstract is read at the publisher; the summary is JClub's.
In 374,973 multiancestry All of Us participants, pathogenic or likely pathogenic variants in 10 MODY genes were found in 1 in 1,013 people, with incomplete penetrance by age 60.
- Why it matters: MODY prevalence and penetrance are not well quantified in multiancestry populations, limiting equitable guidance for genetic testing beyond predominantly European, phenotype-first cohorts.
- What they did: Whole-genome sequencing and clinical data were analyzed in a genotype-first design to estimate carrier prevalence, age-dependent diabetes penetrance, and diabetes risk, including comparisons to noncarriers stratified by T2D PRS.
- The result: Diabetes penetrance was 13.4% by age 40 and 43.5% by age 60, varying by gene (GCK 56.0%, HNF genes 45.4%, non-GCK/HNF genes 29.0%); non-GCK/HNF carriers had HR 1.64, and higher T2D PRS increased risk among carriers (HR per SD 1.32).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.